Cite
Stereotactic radiotherapy combined with immunotherapy or targeted therapy for metastatic renal cell carcinoma.
MLA
Kroeze, Stephanie G. C., et al. “Stereotactic Radiotherapy Combined with Immunotherapy or Targeted Therapy for Metastatic Renal Cell Carcinoma.” BJU International, vol. 127, no. 6, June 2021, pp. 703–11. EBSCOhost, https://doi.org/10.1111/bju.15284.
APA
Kroeze, S. G. C., Fritz, C., Schaule, J., Siva, S., Kahl, K. H., Sundahl, N., Blanck, O., Kaul, D., Adebahr, S., Verhoeff, J. J. C., Skazikis, G., Roeder, F., Geier, M., Eckert, F., & Guckenberger, M. (2021). Stereotactic radiotherapy combined with immunotherapy or targeted therapy for metastatic renal cell carcinoma. BJU International, 127(6), 703–711. https://doi.org/10.1111/bju.15284
Chicago
Kroeze, Stephanie G C, Corinna Fritz, Jana Schaule, Shankar Siva, Klaus H Kahl, Nora Sundahl, Oliver Blanck, et al. 2021. “Stereotactic Radiotherapy Combined with Immunotherapy or Targeted Therapy for Metastatic Renal Cell Carcinoma.” BJU International 127 (6): 703–11. doi:10.1111/bju.15284.